Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds inhibiting leucine-rich repeat kinase enzyme activity

Compounds inhibiting leucine-rich repeat kinase enzyme activity

US Patent 9688654 · Granted Jun 27, 2017

Estimated economic value: $105,730,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
C-terminal SRC kinase inhibitors2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Thyroid hormone receptor agonists2025
Compounds for degrading alpha-synuclein aggregates and uses thereof2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine r2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Heterocyclic compounds, preparation methods and uses thereof2025
EGFR inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Selective estrogen receptor degraders and uses thereof2025
Heterocyclic compounds, preparation methods therefor, and methods of uses thereo2024